Anna Rivkin
Chief Business Officer · Foghorn Therapeutics Inc.
Individual
- 2026
- Feb 2, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Anna Rivkin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anna Rivkin?
Anna Rivkin is a corporate insider, tracked as Chief Business Officer of Foghorn Therapeutics Inc. (FHTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Anna Rivkin last file a Form 4?
The only primary Form 4 on record is dated 2 February 2026.